E

Evotec SE
D

EVO

4.12000
USD
-0.02
(-0.48%)
مغلق
حجم التداول
1,802
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
1,463,039,884
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Evotec SE

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000employees and 18 production sites mainly in Europe and the United States.